Victoria Dimitriades1, Paulo C Rodriguez2, Jovanny Zabaleta3, Augusto C Ochoa4. 1. Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Division of Allergy and Immunology, Children's Hospital of New Orleans, New Orleans, Louisiana. Electronic address: varsen@lsuhsc.edu. 2. Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana. 3. Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana. 4. Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, Louisiana; Division of Allergy and Immunology, Children's Hospital of New Orleans, New Orleans, Louisiana; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana.
Abstract
BACKGROUND: Serum arginase levels have been shown to be elevated in conditions, such as trauma, cancer, chronic wounds, pregnancy, and diabetes. This also has been found to be true in atopic diseases, such as asthma and allergic rhinitis. OBJECTIVE: To study arginase activity in patients with atopic dermatitis (AD). METHODS: In this pilot study, arginase activity levels in 15 pediatric patients with AD were compared with those in controls to determine whether arginase levels in AD are altered as in patients with other atopic diseases. RESULTS: In contrast to the other diseases studied, arginase activity was found to be decreased in granulocytes and in the plasma of patients with AD compared with controls. This finding was coupled with a trend toward higher L-arginine plasma levels. CONCLUSION: In AD, a different mechanism of arginine metabolism seems to be stimulated, leading to the formation of nitric oxide pathway components causing suppression of the arginase pathway and impairment in skin hydration, collagen synthesis, and wound healing.
BACKGROUND: Serum arginase levels have been shown to be elevated in conditions, such as trauma, cancer, chronic wounds, pregnancy, and diabetes. This also has been found to be true in atopic diseases, such as asthma and allergic rhinitis. OBJECTIVE: To study arginase activity in patients with atopic dermatitis (AD). METHODS: In this pilot study, arginase activity levels in 15 pediatric patients with AD were compared with those in controls to determine whether arginase levels in AD are altered as in patients with other atopic diseases. RESULTS: In contrast to the other diseases studied, arginase activity was found to be decreased in granulocytes and in the plasma of patients with AD compared with controls. This finding was coupled with a trend toward higher L-arginine plasma levels. CONCLUSION: In AD, a different mechanism of arginine metabolism seems to be stimulated, leading to the formation of nitric oxide pathway components causing suppression of the arginase pathway and impairment in skin hydration, collagen synthesis, and wound healing.
Authors: Claudia R Morris; Mirjana Poljakovic; Lisa Lavrisha; Lorenzo Machado; Frans A Kuypers; Sidney M Morris Journal: Am J Respir Crit Care Med Date: 2004-04-07 Impact factor: 21.405
Authors: K Nakai; K Yoneda; R Maeda; A Munehiro; N Fujita; I Yokoi; J Moriue; T Moriue; H Kosaka; Y Kubota Journal: J Eur Acad Dermatol Venereol Date: 2009-12 Impact factor: 6.166
Authors: Herman Meurs; Sue McKay; Harm Maarsingh; Marco A M Hamer; Lejla Macic; Niek Molendijk; Johan Zaagsma Journal: Br J Pharmacol Date: 2002-06 Impact factor: 8.739